StockNews.AI
BLCO
StockNews.AI
50 days

Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13

1. BLCO to release Q2 financial results on July 30, 2025. 2. A conference call to discuss results will be held at 8 a.m. ET. 3. An investor day is scheduled for November 13, 2025. 4. Business updates and innovative product pipeline to be highlighted. 5. Company has a diverse portfolio and strong global presence.

Earnings
+9.35%Current Return
VS
+0.58%S&P 500
$12.406/30 07:07 AM EDTEvent Start
$13.5607/01 01:55 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Bullish?

Upcoming financial results and investor day could boost investor confidence, historically similar updates have led to positive stock movement.

How important is it?

Financial results and visibility on the product pipeline can significantly influence stock price trends.

Why Short Term?

Immediate effects expected due to scheduled earnings and investor engagement in November 2025.

Related Companies

LENSAVPHSIC
- VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter financial results on Wednesday, July 30, 2025. The company will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call. Bausch + Lomb will hold an investor day on Thursday, Nov. 13, 2025, where the company will provide a business update and highlight its innovative product pipeline. Additional details will follow closer to the event. Second-Quarter Conference Call Details About Bausch + Lomb Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube. © 2025 Bausch + Lomb. More News From Bausch + Lomb Corporation

Related News